Explore the latest 2025 KDIGO guidelines for IgA Nephropathy. Learn about new prognostic risk models, targeted therapies like Nefecon, and the shift to simultaneous treatment strategies.
Anemia in Kidney Disease: How Erythropoietin and Iron Therapy Work Together
30 January, 2026
Anemia in kidney disease is caused by low erythropoietin and iron dysfunction. Learn how ESA therapy and IV iron work together to improve energy and reduce risks, based on 2025 KDIGO guidelines.